Factor VIII (Shanxi Kangbao Biological Products)

人凝血因子VIII（山西康宝生物）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFactor VIII (Shanxi Kangbao Biological Products)
Drug Alias Name人凝血因子VIII生物仿制药（山西康宝生物）
ClassificationBiologics > Blood componentsBiologics > Protein drugs > Non-recombinant coagulation factorBiologics > Blood components > Non-recombinant coagulation factor
Mechanisms of ActionCoagulation factor VIII replacementsCoagulation factor X stimulantsBlood coagulation pathway activation
TargetsCoagulation factor X
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsHemophilia A
Approved Indications in ChinaHemophilia A
Original Approved Country/TerritoryMainland China
Original Approved Date2020/08/14
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShanxi Kangbao Biological Product Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanxi Kangbao Biological Product Co Ltd
Inactive CompaniesN/A
Active IndicationsHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeB02BD02
Related LinksN/A